BACKGROUND: Ameloblastoma is a benign but locally aggressive odontogenic tumor, while ameloblastic carcinoma is its malignant counterpart. Angiogenesis and lymphangiogenesis in malignancies have been correlated with higher aggressiveness and poor prognosis, as well as greater expression of podoplanin by tumoral cells. METHODS: Immunohistochemical expression of podoplanin, CD34, and CD105 (endoglin) was evaluated in 53 ameloblastomas and three ameloblastic carcinomas; additionally, immunohistochemistry for podoplanin was also performed in 10 tooth germs. Microvessel density of blood and lymphatic vessels was calculated and compared between ameloblastomas and ameloblastic carcinomas. Immunoexpression of podoplanin by ameloblastic cells was evaluated in tooth germs, ameloblastomas, and ameloblastic carcinomas. RESULTS: Podoplanin was similarly expressed by odontogenic epithelial cells of tooth germs and ameloblastomas, while its expression was lower in ameloblastic carcinomas. There was no difference in microvessel density assessed by CD34 between ameloblastomas and ameloblastic carcinomas; nevertheless, the latter presented higher amounts of lymphatic and new formed blood vessels. CONCLUSIONS: Results suggest that podoplanin does not seem to be involved in invasion mechanisms of ameloblastic carcinomas, as its expression was decreased in the malignant tumoral cells. On the other hand, the increased lymphatic microvessel density and neoangiogenesis found in ameloblastic carcinomas could be related to its aggressiveness and potential for metastasis. 
Introduction
Ameloblastoma (AM) is a benign but aggressive odontogenic tumor with high potential for local invasion and recurrence, particularly the solid subtype. Therefore, AM is an important cause of large surgeries in the maxillofacial region (1, 2) . Ameloblastic carcinoma (AC) is the malignant counterpart of AM, with <120 cases reported in the Englishlanguage literature (3) . CD34 is an immunomarker of blood vessel endothelial cells and CD105 (endoglin) is for neoformed vessels, while podoplanin is considered as a reliable immunomarker of lymphatic endothelium. These markers are commonly used to evaluate angiogenesis and lymphangiogenesis in tumors (4, 5) .
The high expression of podoplanin in the basal layer of the oral epithelium and in tooth germ (TG) epithelium, as well as in several squamous cell carcinomas and central nervous system tumors, is possibly related to ectodermal cell proliferation (6) . Podoplanin also seems to be involved in odontoblasts growth and with the extension of odontoblastic fibers, which is mediated by cytoskeleton rearrangements. Thus, reduction in odontoblastic expression of podoplanin is observed with the completion of tooth formation (7) .
Podoplanin can be expressed both in specific cell types of normal tissues as well as in tumoral cells of benign and malignant neoplasms, and it has been correlated with aggressiveness, tumor spread, metastasis, and poor prognosis (8) .
The aims of this study were to describe and quantitate angiogenesis and lymphangiogenesis in AM and AC, and to compare the expression of podoplanin in ameloblastic cells of TG, ameloblastomas, and ameloblastic carcinomas, to better understand whether these parameters might be associated with the aggressiveness of these tumors. Immunohistochemical reactions were performed in 3-lm sections of formalin-fixed, paraffin-embedded tissues that were dewaxed with xylene and then hydrated in an ethanol series. Antigen retrieval was performed by immersing the sections for 3 min in citrate buffer solution (pH 6.0) in a pressure cooker for podoplanin and CD34 reactions, while for CD105, enzymatic digestion was applied for 5 min using Proteinase K (DAKO, Cytomation, Carpinteria, CA, USA, ready to use). Endogenous peroxidase activity was blocked using 10% hydrogen peroxide in five baths, each of 5 min. Subsequently, preparations were washed in phosphate buffer solution (pH 7.4) and incubated overnight with the primary antibody anti-human podoplanin (Dako Cytomation, clone D2-40, diluted 1:100); anti-CD34 (Dako Cytomation, clone QBEnd-10, diluted 1:50); and anti-CD105 (endoglin) (Dako Cytomation, clone SN6h, diluted 1:30). All slides were then exposed to avidin-biotin complex and horseradish peroxidase reagents (LSAB Kit; Dako Cytomation) and diaminobenzidine tetrahydrochloride (DAB; Sigma-Aldrich, St Louis, MO, USA). Finally, the tissue sections were counterstained with Carazzi hematoxylin. Kaposi sarcoma was used as positive control for podoplanin and pyogenic granuloma for CD34 and CD105, while the negative control was obtained by omitting the specific primary antibody.
Materials and methods
The expression of podoplanin in the ameloblastic cells was evaluated in the whole section of each case, performing a modification of the method of Yuan et al. (10) , which takes into consideration three main features: the percentage of positive tumoral area (from 0% to 100%), intensity of staining (weak, moderate, and strong, based on the optical density of stain), and the patterns of expression within tumoral nests; however, differently from the abovementioned authors, we did not use scoring, describing separately these three aspects. Three patterns of expression within tumoral nests were considered: (i) intense staining at the peripheral/basal layer of islands (ameloblastic-like cells) and weak or negative at central cells (stellated reticulum-like cells); (ii) higher expression at the central/suprabasal cells (stellated reticulum-like cells) than in peripheral/ameloblastic cells; and (iii) full staining of islands, with similar intensity in center and peripheral cells.
Lymphatic microvascular density (LMVD)
Due to the low quantity of lymphatic vessels (LVs), the LMVD was obtained manually, based on the method initially described by Weidner (11) , and used in several studies to determine microvessel density (12, 13) . Briefly, at low magnification (109), three 'hot spots' with high number of podoplanin-positive LV are localized. Subsequently, counting was performed in each area at a highpower magnification field (409). LMVD was expressed as the number of LVs per square millimeter, and it was obtained by dividing the total number of LVs by the total area analyzed in mm 2 for each case, that is, 0.456 mm 2 .
Digital analysis for microvessel density (MVD)
The MVD of blood vessels stained with CD34 and CD105 was obtained by digital analysis. The slides were scanned into high-resolution images using the Aperio ScanScope CS Slide Scanner (Aperio Technologies Inc, Vista, CA, USA). All digital images obtained in.svs format were visualized with the ImageScope software (Aperio Technologies Inc). Microvessel Analysis v1 algorithm (Aperio Technologies Inc) was used to quantitate the number of vessels by CD34 and CD105 reactivity. The values of MVD were expressed as the number of vessels per unit area (lm 2 ) (Fig. 1 ). Statistical analysis was performed for LMVD and MVD separately, using testing frequencies for qualitative variables, whereas for the quantitative data, comparative analyses were performed using the chi-squared test, Student's t-test, and ANOVA test. We have added nonparametric statistics for comparison of the three groups using the Kruskal-Wallis test. The results were considered significant when P ≤ 0.05. 
J Oral Pathol Med
Podoplanin expression in ameloblastomas S anchez-Romero et al.
Results
All TGs expressed podoplanin in the epithelial elements of the enamel organ. The percentage of positive area of odontogenic epithelial tissue varied from 50% to 100%, with a mean of 79%. Localization of staining in the TG cells varied slightly throughout the maturation stage. In the bud stage, podoplanin showed intense membrane/cytoplasmic expression in both peripheral ameloblastic and central cells that would lead to stellate reticulum, and this expression was also seen in continuity with the basal layer of the oral epithelium ( Fig. 2A) . In cap stage, podoplanin was intensely positive in the cytoplasm of cells of the inner and outer enamel epithelium, with focally negative areas at the cervical loop, stratum intermedium, and stellated reticulum (Fig. 2B) . At the bell stage, the pre-secretory and secretory ameloblasts had strong membrane positivity and clear cytoplasm, with the recently differentiated odontoblasts and adjacent dental papilla also showing cytoplasmic and membrane positivity, respectively (Fig. 2C ).
All cases of AM presented membrane and cytoplasmic positivity for podoplanin: in eight (14%) cases, staining was weak; in 13 (22.8%), moderate; and in 36 (63.2%), strong. Percentage of positive tumoral area ranged from 10% to 100% with a mean of 84%. In 82.4% of AM, podoplanin was expressed strongly at the peripheral/basal ameloblastic cells, being weak/negative in the central/suprabasal cells that resemble the stellated reticulum (Fig. 2D) , while 17.6% of the cases stained with similar intensity in both center and peripheral cells (Fig. 2E ). There were not any AM positive predominantly at the center of the islands and negative at the periphery. In most cases, focal negative areas were found.
Thirty-three of 38 cases of SA (86.85%) presented podoplanin expression predominantly at the peripheral/ ameloblastic layer (Fig. 2D) , while five (13.15%) showed similar staining in peripheral and central cells of tumor islands (Fig. 2E) . Comparing the expression of podoplanin between SA and UA, we observed a similar pattern of expression; however, the percentage of positive tumoral area was lower in SA (62% of positivity) than in UA (88% 
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of positivity). Twelve of 15 cases of UA (80%) showed podoplanin positivity restricted to the basal layer, while in three cases (20%), the whole thickness of the epithelial cystic lining (basal and suprabasal layers) was positive. Similar to SA, most cases of UA had intense staining. The mean LMVD of the 53 cases of AM was 18.7 (20.2 for SA and 13.8 for UA). In 12 (24.5%) cases of AM, LVs were not found (seven SA representing 18.4% of SA and five UA representing 33.3% of UA). It was difficult to determine tumoral LV hot spots in AM because of the scarce presence of LV (Fig. 2F) .
The three cases of AC expressed podoplanin ranging from 10% to 50%, with a mean of 27% of positive tumor area. In contrast to AM, two AC (66.6%) stained predominantly at the center of the islands, with weak to strong intensity (Fig. 3A,B) , and one case had only 10% of weak positivity, mainly in cell clusters within islands. More frequently, extensive negative areas were observed in AC than in AM.
The mean LMVD of the three ACs was 73.09. In contrast to AM, LV hot spots adjacent to tumoral cells were commonly observed (Fig. 3C,D) . In AC, the LMVD index was statically higher than in AM (Mann-Whitney U-test, P = 0.000), while it was similar when SA and UA were compared (Fig. 4) . In TG, lymphatic vessels were not present. As positive control, lymphatic vessels were observed adjacent to the oral epithelium.
In all cases of AM and AC, immunoreactivity for CD34 and CD105 was detected in the cytoplasm of endothelial cells of blood vessels in the peritumoral and intratumoral stroma (Fig. 5) . In most follicular SA and UA, positive vessels had a peritumoral disposition (Fig. 5A,B) , while in most cases of plexiform SA and AC, the vessels were frequently located in intratumoral niches (Fig. 5C-F) .
Mean values of MVD in AM and AC are shown in Figure 6 . MVD assessed by CD34 (MVD-CD34) was similar between SA and UA, and between AM and CA; however, MVD evaluated with CD105 (MVD-CD105) showed a tendency to be higher in SA than in UA, and it was significantly higher in AC than in AM (Fig. 6) . 
There were not significant differences in the expression of podoplanin, LMVD, and MVD between histologic variants of UA (mural, intraluminal, and luminal), nor between subtypes of SA (plexiform and follicular).
Blood vessels were not quantified in TG, because of the reduced size of the area in which they could be found, consequently, it could not be applied the same methodology of vessel counting used for AM and AC (five areas of 600 000 lm 2 analyzed in each case). Also, we considered that the ectomesenchymal tissue that surrounds TG (dental papilla and dental follicle) is different from the fibrous connective tissue that conforms the stroma of AM and AC.
Discussion
Our results confirm that podoplanin is strongly expressed in TG, with slight pattern variations along maturation stages, according to previous studies in mouse and human TG (7). These results indicate that podoplanin plays a role in tooth development by cytoskeleton rearrangements of epithelial odontogenic cells and odontoblasts (6, 14) . All AM also expressed podoplanin strongly, confirming recent studies (15, 16) . There are no previous reports of podoplanin in AC, but our results show that expression is decreased on this malignancy in relation to AM. In neoplastic tissues, podoplanin has been related to higher aggressiveness (17) , but this was not confirmed for SA and AC in relation to UA which is well accepted to be a less aggressive ameloblastic tumor (14, 16) . As cited, TG used as normal control was strongly positive for podoplanin, and UA showed a similar or slightly higher expression than SA. In fact, AC was the group with the lowest expression, suggesting that podoplanin does not seem to play an important role related to the aggressiveness of this malignancy. These results should be carefully considered as we studied only three cases of AC, which is a very rare malignant odontogenic tumor.
Expression of podoplanin in AM and other odontogenic tumors and cystic odontogenic lesions has been described most frequently as positive at the peripheral/basal cells and negative or slightly positive at central/suprabasal cells (14, (15) . The role of podoplanin in developmental, reactive, and neoplastic odontogenic epithelium is not yet well established, but it could be related to cytoskeletal reorganization in physiologic and pathologic processes as for example TG morphodifferentiation, local expansion of odontogenic cystic lesions, and invasion/ migration in some odontogenic tumors such as AM (14, 15) . This is the first study that describes, quantitates, and compares the LV in TG, AM, and AC. In TG, LVs were absent and AM presented scarce LVs that frequently were not closely associated with the ameloblastic epithelium, while in AC, the LVs were mostly adjacent to the tumoral cells. Recently, Sousa-Neto et al. (19) found higher number of LV in keratocystic odontogenic tumor (KCOT) as compared to radicular cysts and pericoronal follicles, and the localization of LV in KCOT was distant from the epithelium, likewise to our observations in AM. AC presented a significantly higher LMVD than AM, and this could play a role in favoring metastases by lymphatic tumoral dissemination, as around a third of cases of AC results in tumor-related death or pulmonary metastasis (9).
Watanabe et al. (20) found in squamous cell carcinomas of lip and oral cavity a decrease in LMVD with tumor progression using podoplanin as a marker, possibly due to damage of LV by tumoral cells. Conversely, in our study, we found a significantly higher quantity of LV in AC than in AM and TG. To confirm these findings in AC, it would be interesting to study additional cases of this very rare neoplasm and compare the LMVD across the tumoral progression.
CD34 is consistently positive for vascular endothelium while CD105 is highly expressed in endothelium of neoformed or angiogenic active vessels, but minimally expressed in pre-existent and quiescent vessels (21, 22) . Therefore, they are routinely used to quantitate total and neoformed blood vessels, respectively (5). It is controversial whether MVD is similar or not in SA and UA (2, 23) , and our results did not show significant differences when comparing MVD-CD34 in SA and UA.
Nevertheless, MVD-CD105 immunoexpression showed a tendency to be higher in SA than UA (P = 0.062). A higher MVD was described in recurrent and malignant ameloblastomas than in primary ameloblastomas (2, 23, 24 ), but we found that AM and AC did not present differences in MVD-CD34. However, MVD-CD105 was significantly higher in AC than in AM, suggesting that AC has a greater angiogenic potential.
Tumor growth depends on blood supply for nutrients and oxygen needs; thus, higher neoangiogenesis and LMVD in AC could be related to expression of hypoxia-inducible factor-1a (HIF-1a), as we showed in a previous study (25) , as this transcriptor factor of VEGF and VEGF-C promotes angiogenesis and lymphangiogenesis (14, 26) . In fact, MVD in AM was related to the expression of VEGFs by the odontogenic tumoral cells (4) .
In summary, this is the first study that compares podoplanin expression in ameloblastic cells of TG, AM, and AC, also quantitates LMVD and compares the total amount of blood vessels vs. neoformed vessels in AM and AC. AC showed higher peritumoral lymphatic vascularization which could be related to its metastatic potential. TG and AM had similar expression of podoplanin, while in AC, it was significantly decreased, suggesting that podoplanin may not be related to the aggressiveness of this malignant odontogenic tumor. Also, higher neoangiogenesis was present in the more aggressive SA and AC, than in UA. Future studies with larger samples of AC may contribute to a better understanding of the role of podoplanin, lymphangiogenesis, and neoangiogenesis in the pathogenesis and biologic behavior of malignant odontogenic tumors.
